ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2018, Vol. 27 ›› Issue (4): 374-378.DOI: 10.3969/j.issn.1006-298X.2018.04.017

• 论文 • 上一篇    下一篇

肥胖致肾脏病的发病机制及治疗进展

  

  • 出版日期:2018-08-28 发布日期:2018-08-31

Mechanisms and treatment of obesity related kidney disease

  • Online:2018-08-28 Published:2018-08-31

摘要:

随着人口老龄化、生活方式和饮食结构的改变,肥胖、2型糖尿病及高血压病等代谢相关性疾病的发病率逐年增加,它们均可增加肾脏疾病的发生风险,使慢性肾脏病的患病率呈递增趋势。研究发现肥胖状态下肾脏损伤与蛋白尿产生、代谢调节失衡、肠道菌群紊乱及内分泌激素水平变化有关,导致炎症反应,加速肾小球硬化和小管间质萎缩。肥胖相关性肾脏疾病的治疗方式主要包括饮食控制和规律运动,减重药物和手术适用于特定人群。肥胖与肾脏疾病发病机制的进一步研究有助于制定个体化疗法,更好地干预肥胖相关性肾病的进展。

关键词: 肥胖, 慢性肾脏病, 炎症反应, 肠道菌群, 治疗

Abstract:

With the ageing population,changing of lifestyles and dietary structure,the morbidity of metabolic diseases such as obesity,type 2 diabetes mellitus(T2DM) and hypertension has increased by years,thus further increasing the risk of kidney disease,and presenting a globally increasing trend.Researches showed that occurrence of proteinuria,unbalanced metabolism,intestinal dysbiosis and abnormal hormone levels are associated with kidney damage in obese individuals.Inflammation is promoted and glomerular sclerosis and tubular interstitial atrophy are accelerated.Therapies to obesity related glomerulopathy mainly include dietary intervention and regular exercise,and oral drugs,bariatric surgery for specific people.Future studies should be focus on the pathogenesis between obesity and chronic renal disease to retard the progression of obesity related kidney disease.

Key words: obesity, chronic kidney disease, inflammatory response, intestinal floratherapy